Immunis Chairman Dr. Hans Keirstead Nominated to Speak at SXSW 2027 on Restorative Approaches to Longevity Medicine

Immunis Chairman Dr. Hans Keirstead Nominated to Speak at SXSW 2027 on Restorative Approaches to Longevity Medicine

Nominated panel at SXSW’s annual festival for health innovators, technologists, clinicians, and biotech pioneers explores how evidence-based science is shaping how we age and restore muscle function

Immunis, Inc., a clinical-stage biotechnology company developing off-the-shelf multi-active biologics for muscle health and healthy aging, today announced that its Chairman, Dr. Hans Keirstead, has been nominated as a panelist at SXSW 2027 in a conversation titled "Can We Get Better at Aging?: Hope, Hype, and Hard Science."

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260820530313/en/ Dr. Hans Keirstead, Chairman of Immunis, is honored by the nomination to be a panelist for SXSW's discussion on "Restorative Approaches to Longevity Medicine."

As medicine shifts from managing the effects of aging to designing therapeutics that help the body restore function, demand is growing for therapies that preserve muscle and metabolic health with age.